SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

Inhibitors of HBV replication of Formula (ID)including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein X, Rato Rdand R4to R6have the meaning as defined herein.The present invention also relates to processes for preparing said compounds, pharmaceutical compositions con...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LAST, Stefaan Julien, VERSCHUEREN, Wim Gaston, RABOISSON, Pierre Jean-Marie Bernard, VANDYCK, Koen, HACHÉ, Geerwin Yvonne Paul, MC GOWAN, David Craig, ROMBOUTS, Geert
Format: Patent
Sprache:eng ; ita
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LAST, Stefaan Julien
VERSCHUEREN, Wim Gaston
RABOISSON, Pierre Jean-Marie Bernard
VANDYCK, Koen
HACHÉ, Geerwin Yvonne Paul
MC GOWAN, David Craig
ROMBOUTS, Geert
description Inhibitors of HBV replication of Formula (ID)including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein X, Rato Rdand R4to R6have the meaning as defined herein.The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SMT202000228TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SMT202000228TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SMT202000228TT13</originalsourceid><addsrcrecordid>eNqNzLEKwjAQxvEuDqK-ww2uQoyL67W5kkDTlNy10KkUiZNoob4_tuIDOP3h48e3zRK3VWPRh75q-hhDhd4ZAkPRdSiuIwasDYglaJnWRgolIIMn4wr0VAtDGeKXSCSUdYLFWGqWB3EM-T7b3MfHnA6_7rJjSVLYU5peQ5qn8Zae6T2wF620Ukrrq8j58if7AAGWNs4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B</title><source>esp@cenet</source><creator>LAST, Stefaan Julien ; VERSCHUEREN, Wim Gaston ; RABOISSON, Pierre Jean-Marie Bernard ; VANDYCK, Koen ; HACHÉ, Geerwin Yvonne Paul ; MC GOWAN, David Craig ; ROMBOUTS, Geert</creator><creatorcontrib>LAST, Stefaan Julien ; VERSCHUEREN, Wim Gaston ; RABOISSON, Pierre Jean-Marie Bernard ; VANDYCK, Koen ; HACHÉ, Geerwin Yvonne Paul ; MC GOWAN, David Craig ; ROMBOUTS, Geert</creatorcontrib><description>Inhibitors of HBV replication of Formula (ID)including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein X, Rato Rdand R4to R6have the meaning as defined herein.The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.</description><language>eng ; ita</language><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200708&amp;DB=EPODOC&amp;CC=SM&amp;NR=T202000228T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200708&amp;DB=EPODOC&amp;CC=SM&amp;NR=T202000228T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LAST, Stefaan Julien</creatorcontrib><creatorcontrib>VERSCHUEREN, Wim Gaston</creatorcontrib><creatorcontrib>RABOISSON, Pierre Jean-Marie Bernard</creatorcontrib><creatorcontrib>VANDYCK, Koen</creatorcontrib><creatorcontrib>HACHÉ, Geerwin Yvonne Paul</creatorcontrib><creatorcontrib>MC GOWAN, David Craig</creatorcontrib><creatorcontrib>ROMBOUTS, Geert</creatorcontrib><title>SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B</title><description>Inhibitors of HBV replication of Formula (ID)including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein X, Rato Rdand R4to R6have the meaning as defined herein.The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzLEKwjAQxvEuDqK-ww2uQoyL67W5kkDTlNy10KkUiZNoob4_tuIDOP3h48e3zRK3VWPRh75q-hhDhd4ZAkPRdSiuIwasDYglaJnWRgolIIMn4wr0VAtDGeKXSCSUdYLFWGqWB3EM-T7b3MfHnA6_7rJjSVLYU5peQ5qn8Zae6T2wF620Ukrrq8j58if7AAGWNs4</recordid><startdate>20200708</startdate><enddate>20200708</enddate><creator>LAST, Stefaan Julien</creator><creator>VERSCHUEREN, Wim Gaston</creator><creator>RABOISSON, Pierre Jean-Marie Bernard</creator><creator>VANDYCK, Koen</creator><creator>HACHÉ, Geerwin Yvonne Paul</creator><creator>MC GOWAN, David Craig</creator><creator>ROMBOUTS, Geert</creator><scope>EVB</scope></search><sort><creationdate>20200708</creationdate><title>SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B</title><author>LAST, Stefaan Julien ; VERSCHUEREN, Wim Gaston ; RABOISSON, Pierre Jean-Marie Bernard ; VANDYCK, Koen ; HACHÉ, Geerwin Yvonne Paul ; MC GOWAN, David Craig ; ROMBOUTS, Geert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SMT202000228TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; ita</language><creationdate>2020</creationdate><toplevel>online_resources</toplevel><creatorcontrib>LAST, Stefaan Julien</creatorcontrib><creatorcontrib>VERSCHUEREN, Wim Gaston</creatorcontrib><creatorcontrib>RABOISSON, Pierre Jean-Marie Bernard</creatorcontrib><creatorcontrib>VANDYCK, Koen</creatorcontrib><creatorcontrib>HACHÉ, Geerwin Yvonne Paul</creatorcontrib><creatorcontrib>MC GOWAN, David Craig</creatorcontrib><creatorcontrib>ROMBOUTS, Geert</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LAST, Stefaan Julien</au><au>VERSCHUEREN, Wim Gaston</au><au>RABOISSON, Pierre Jean-Marie Bernard</au><au>VANDYCK, Koen</au><au>HACHÉ, Geerwin Yvonne Paul</au><au>MC GOWAN, David Craig</au><au>ROMBOUTS, Geert</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B</title><date>2020-07-08</date><risdate>2020</risdate><abstract>Inhibitors of HBV replication of Formula (ID)including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein X, Rato Rdand R4to R6have the meaning as defined herein.The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; ita
recordid cdi_epo_espacenet_SMT202000228TT1
source esp@cenet
title SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T20%3A28%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LAST,%20Stefaan%20Julien&rft.date=2020-07-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESMT202000228TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true